Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ana Luiza de Freitas Magalhães Gomes"'
Autor:
Erick de Matos Santos, Thayse Batista Moreira, Ana Luiza de Freitas Magalhães Gomes, Ana Paula Alvares Ramos, Fábio Ribeiro Queiroz, Paulo Guilherme de Oliveira Salles, Letícia Conceição Braga
Publikováno v:
Mastology.
Objective: The objective of this study was to standardize the Ficoll gradient technique for the circulating hematopoietic stem cell (HSC) isolation for the assembly of the peripheral blood mononuclear cell (PBMC) biorepository of breast cancer (BC) p
Autor:
Thayse Batista Moreira, Marina Malheiros Araújo Silvestrini, Ana Luiza de Freitas Magalhães Gomes, Erick Matos Santos, Paulo Guilherme de Oliveira Salles, Letícia Conceição Braga, Andréa Teixeira de Carvalho
Publikováno v:
Mastology.
Objective: Due to the already observed importance of neutrophil-derived microvesicles (NMVs) in cancer development and progression, this study aims to quantify NMVs according to clinical staging and histological grade in the blood of breast cancer (B
Autor:
Letícia da Conceição Braga, Thayse Batista Moreira, Ana Luiza de Freitas Magalhães Gomes, Matheus Gomes de Souza, Paulo Guilherme de Oliveira Salles, Fábio Ribeiro Queiroz
Publikováno v:
Mastology.
Objective: The identification and characterization of miRNAs derived from microvesicles of breast cancer patients is the main goal of this study. Methods: A cohort of 28 patients was evaluated, 28.6% are HER2 overexpressed, 46.4% are triple-negative,
Autor:
Kerstin Kapp Rangel, Paulo Guilherme de Oliveira Salles, Ana Luiza de Freitas Magalhães Gomes, Wagner Antonio Paz, Marina Paixão de Madrid Whyte
Publikováno v:
Mastology. 30
Introduction: Triple-negative breast cancer (TNBC) does not express estrogen and progesterone receptors, and does not overexpress the human epidermal growth factor 2. It represents 15%‒20% of breast cancers and have worse prognosis, with scarce ava